Skip to main content
placeholder image

Combination therapy with gefitinib (ZD1839) and rofecoxib in platinum-pretreated relapsed non-small-cell lung cancer (NSCLC)

Journal Article


Abstract


Publication Date


  • 2004

Citation


  • O'Byrne, K., Clarke, L., Dunlop, D., Ranson, M., Danson, S., Botwood, N., & Carbone, D. (2004). Combination therapy with gefitinib (ZD1839) and rofecoxib in platinum-pretreated relapsed non-small-cell lung cancer (NSCLC). Journal of Clinical Oncology, 22(14_suppl), 7101. doi:10.1200/jco.2004.22.90140.7101

Web Of Science Accession Number


Start Page


  • 7101

End Page


  • 7101

Volume


  • 22

Issue


  • 14_suppl

Place Of Publication


Abstract


Publication Date


  • 2004

Citation


  • O'Byrne, K., Clarke, L., Dunlop, D., Ranson, M., Danson, S., Botwood, N., & Carbone, D. (2004). Combination therapy with gefitinib (ZD1839) and rofecoxib in platinum-pretreated relapsed non-small-cell lung cancer (NSCLC). Journal of Clinical Oncology, 22(14_suppl), 7101. doi:10.1200/jco.2004.22.90140.7101

Web Of Science Accession Number


Start Page


  • 7101

End Page


  • 7101

Volume


  • 22

Issue


  • 14_suppl

Place Of Publication